Defence Therapeutics Inc (DTC.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in thousands)
| 06-2025 | 06-2024 | 06-2023 | 06-2022 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,232 | 57 | 2,793 | 507 | 5,453 |
| Receivables | 198 | 97 | 150 | 28 | 72 |
| TOTAL | $1,464 | $214 | $3,435 | $674 | $5,563 |
| Non-Current Assets | |||||
| PPE Net | 188 | 264 | 59 | N/A | N/A |
| Intangibles | N/A | 0 | 39 | 46 | 46 |
| TOTAL | $188 | $264 | $98 | $46 | $46 |
| Total Assets | $1,652 | $478 | $3,533 | $720 | $5,609 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 1,711 | N/A | N/A | N/A |
| TOTAL | $1,418 | $4,054 | $220 | $1,107 | $122 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,489 | N/A | 1,746 | N/A | N/A |
| TOTAL | $1,489 | $8 | $1,746 | $0 | $0 |
| Total Liabilities | $2,907 | $4,062 | $1,967 | $1,107 | $122 |
| Shareholders' Equity | |||||
| Common Shares | 24,191 | 19,242 | 16,951 | 9,334 | 7,971 |
| Retained earnings | -29,306 | -29,808 | -16,907 | -10,516 | -3,533 |
| Other shareholders' equity | 3,859 | 6,981 | 1,522 | 794 | 1,048 |
| TOTAL | $-1,256 | $-3,584 | $1,566 | $-388 | $5,487 |
| Total Liabilities And Equity | $1,652 | $478 | $3,533 | $720 | $5,609 |